AstraZeneca

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed.

CEO

Pascal Soriot

CEOPascal Soriot

Employees

94,300

Employees94,300

Headquarters

Cambridge, Cambridgeshire

HeadquartersCambridge, Cambridgeshire

Founded

1913

Founded1913

Employees

94,300

Employees94,300

AZN Key Statistics

Market cap

243.26B

Market cap243.26B

Price-Earnings ratio

29.64

Price-Earnings ratio29.64

Dividend yield

1.93%

Dividend yield1.93%

Average volume

3.17M

Average volume3.17M

High today

$78.52

High today$78.52

Low today

$77.39

Low today$77.39

Open price

$78.27

Open price$78.27

Volume

4.45M

Volume4.45M

52 Week high

$82.41

52 Week high$82.41

52 Week low

$61.24

52 Week low$61.24

AZN News

Seeking Alpha 3d

AstraZeneca follows Merck’s pullback in Britain: report

Healthcare AstraZeneca follows Merck’s pullback in Britain: report Sep. 12, 2025 1:59 PM ET AstraZeneca PLC (AZN) Stock, MRK Stock By: Dulan Lokuwithana, SA New...

TipRanks 4d

AstraZeneca pauses planned $270M investment in Britain, Reuters reports

Britain’s biggest company AstraZeneca (AZN) has paused a planned $271.26M investment in its Cambridge research site, a spokesperson said, the latest drugmaker t...

TipRanks 5d

AstraZeneca announces EMA validation for Enhertu marketing authorization

The European Medicines Agency has validated the Type II Variation marketing authorization application for Enhertu for the treatment of adult patients with HER2...

Analyst ratings

80%

of 30 ratings

Buy

80%

Hold

20%

Sell

More AZN News

TipRanks 6d

FDA expands approval of AstraZeneca’s Koselugo

The Food and Drug Administration said it approved AstraZeneca’s (AZN) Koselugo for pediatric patients one year of age and older with neurofibromatosis type 1 wh...

TipRanks 7d

AstraZeneca’s AZD2389 Phase I Study Completion: Key Insights for Investors

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...